Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Phase II Open Label Trial to Investigate the Efficacy and Safety of Intra-dermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus

NCT02656082 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT02656082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02656082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Phase II Open Label Trial to Investigate the Efficacy and Safety of Intra-dermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Lead sponsor
University of Leeds
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2016
Completion date
December 31, 2017
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lupus erythematosus, chronic cutaneous, lupus erythematosus, cutaneous, lupus erythematosus, discoid